Volatile compounds in health and disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 5, 2011, Pages 455-460

  Španěl, Patrik ^a   Smith, David ^b  

^a J HEYROVSKÝ INSTITUTE OF PHYSICAL CHEMISTRY   (Czech Republic)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

acetone; ammonia; breath analysis; hydrogen; volatile organic compounds

Indexed keywords

ACETONE; AMMONIA; CARBON 13; HYDROGEN; HYDROGEN CYANIDE; METHANE; VOLATILE AGENT;

BODY FLUID; BREATH ANALYSIS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CYSTIC FIBROSIS; DIABETES MELLITUS; DIET; GASTROINTESTINAL TRANSIT; HEALTH STATUS; HUMAN; MASS SPECTROMETRY; METABOLITE; NUTRITIONAL ASSESSMENT; REVIEW; STOMACH EMPTYING;

ACETONE; AMMONIA; BREATH TESTS; CARBON DIOXIDE; HEALTH STATUS; HUMANS; HYDROGEN; HYDROGEN CYANIDE; MASS SPECTROMETRY; NUTRITIONAL STATUS; RESPIRATORY SYSTEM; TRACE ELEMENTS; VOLATILE ORGANIC COMPOUNDS;

PSEUDOMONAS;

EID: 80051752040     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283490280     Document Type: Review

References (69)

1. Amann A, Smith D, editors. Breath analysis for clinical diagnosis and therapeutic monitoring. World Scientific: Singapore; 2005. p. 536.
2. Sachs-Olsen C, Carlsen KCL, Mowinckel P, et al. Diagnostic value of exhaled nitric oxide in childhood asthma and allergy. Pediatr Allergy Immunol 2010;21:E213-E221.
3. Dweik RA, Sorkness RL, Wenzel S, et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010;181:1033-1041. An extensive study showing that exhaled NO has not only diagnostic potential, but also that its concentration can identify the most-at-risk asthma patients.
4. Španěl P, Smith D. Progress in SIFT-MS: breath analysis and other applications. Mass Spectrom Rev 2011;30:236-267. A comprehensive review based on relevant SIFT-MS breath analysis research and associated topics since 2005.
5. Smith D, Španěl P. Ambient analysis of trace compounds in gaseous media by SIFT-MS. Analyst 2011;136:2009-2032. This is a tutorial review of the fundamental principles and recent developments of the SIFT-MS technique, focusing on ambient analysis and breath analysis.
6. King J, Mochalski P, Kupferthaler A, et al. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study. Physiol Meas 2010;31:1169-1184.
7. Fedrigo M, Hoeschen C, Oeh U. Multidimensional statistical analysis of PTR-MS breath samples: a test study on irradiation detection. Int J Mass Spectrom 2010;295:13-20.
8. Boshier PR, Marczin N, Hanna GB. Repeatability of the measurement of exhaled volatile metabolites using selected ion flow tube mass spectrometry. J Am Soc Mass Spectrom 2010;21:1070-1074. An independent, careful study of the clinical reliability of SIFT-MS for breath analysis.
9. King J, Koc H, Unterkofler K, et al. Physiological modeling of isoprene dynamics in exhaled breath. J Theoret Biol 2010;267:626-637. Very thorough theoretical and experimental study explaining the mechanism of changes in breath isoprene.
10. Smith D, Spanel P, Enderby B, et al. Isoprene levels in the exhaled breath of 200 healthy pupils within the age range 7-18 years studied using SIFT-MS. J Breath Res 2010;4:017101.
11. Dryahina K, Smith D, Spanel P. Quantification of methane in humid air and exhaled breath using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 2010;24:1296-1304.
12. Smith D, Pysanenko A, Španěl P. Kinetics of ethanol decay in mouth-and nose-exhaled breath measured on-line by selected ion flow tube mass spectrometry following varying doses of alcohol. Rapid Commun Mass Spectrom 2010;24:1066-1074.
13. Fuchs P, Loeseken C, Schubert JK, et al. Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer 2010;126:2663-2670. An interesting study of breath biomarkers of lung cancer.
14. Song G, Qin T, Liu H, et al. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer 2010;67:227-231. An interesting study of VOC exhaled breath biomarkers of nonsmall cell lung cancer.
15. Martin AN, Farquar GR, Jones AD, et al. Human breath analysis: methods for sample collection and reduction of localized background effects. Anal Bioanal Chem 2010;396:739-750. An interesting state-of-the art study on SPME methodology for breath sampling.
16. Reynolds JC, Blackburn GJ, Guallar-Hoyas C, et al. Detection of volatile organic compounds in breath using thermal desorption electrospray ionization-ion mobility-mass spectrometry. Anal Chem 2010;82:2139-2144. This study describes the unique combination of ion mobility spectrometry (IMS) with mass spectrometry.
17. Wzorek B, Mochalski P, Sliwka I, et al. Application of GC-MS with a SPME and thermal desorption technique for determination of dimethylamine and trimethylamine in gaseous samples for medical diagnostic purposes. J Breath Res 2010;4:026002.
18. Baumbach JI. Ion mobility spectrometry coupled with multicapillary columns for metabolic profiling of human breath. J Breath Res 2009;3:034001.
19. Lindberg DA. Hydrogen breath testing in adults: what is it and why is it performed? Gastroenterol Nurs 2010;33:8-13. A concise introduction to the significance of hydrogen breath testing and its value and significance in clinical diagnosis.
20. Corlew-Roath M, Di Palma JA. Clinical impact of identifying lactose maldigestion or fructose malabsorption in irritable bowel syndrome or other conditions. South Med J 2009;102:101 0-1012.
21. Turner C, Španěl P, Smith D. A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry, SIFT-MS. Physiol Meas 2006;27:321-337.
22. Dummer JF, Storer MK, Hu WP, et al. Accurate, reproducible measurement of acetone concentration in breath using selected ion flow tube-mass spectrometry. J Breath Res 2010;4:046001.
23. Greiter MB, Keck L, Siegmund T, et al. Differences in exhaled gas profiles between patients with type 2 diabetes and healthy controls. Diabetes Technol Ther 2010;12:455-463. An interesting study indicating the potential of volatile breath biomarkers for monitoring type 2 diabetes.
24. Righettoni M, Tricoli A, Pratsinis SE. Thermally stable, silica-doped epsilon-WO3 for sensing of acetone in the human breath. Chem Mater 2010;22:3152-3157.
25. Denzer W, Hancock G, Islam M, et al. Trace species detection in the near infrared using Fourier transform broadband cavity enhanced absorption spectroscopy: initial studies on potential breath analytes. Analyst 2011;136:801-806.
26. Wang CJ, Mbi A, Shepherd M. A study on breath acetone in diabetic patients using a cavity ringdown breath analyzer: exploring correlations of breath acetone with blood glucose and glycohemoglobin A1C. IEEE Sensors J 2010;10:54-63. A thorough study of breath acetone and its relation to blood glucose and diabetes using a promising spectroscopic technique.
27. Smith D, Spanel P, Davies S. Trace gases in breath of healthy volunteers when fasting and after a protein-calorie meal: a preliminary study. J Appl Physiol 1999;87:1584-1588.
28. Spanel P, Davies S, Smith D. Breath ammonia dips after feeding independently of the protein content of the meal. FASEB J 2000;14:A490-A1490.
29. Spanel P, Dryahina K, Rejskova A, et al. Breath acetone concentration; biological variability and the influence of diet. Physiol Meas 2011;32:N23-N31.
30. Davies S, Spanel P, Smith D. Quantitative analysis of ammonia on the breath of patients in end-stage renal failure. Kidney Int 1997;52:223-228. (Pubitemid 27321835)
31. Endre ZH, Pickering JW, Storer MK, et al. Breath ammonia and trimethylamine allow real-time monitoring of haemodialysis efficacy. Physiol Meas 2011;32:115-130.
32. Ishida H, Satou T, Tsuji K, et al. The breath ammonia measurement of the hemodialysis with a QCM-NH3 sensor. BioMed Mater Eng 2008;18:99-106. (Pubitemid 352040124)
33. Hibbard T, Killard AJ. Breath ammonia analysis: clinical application and measurement. Crit Rev Anal Chem 2011;41:21-35.
34. Boshier PR, Cushnir JR, Priest OH, et al. Variation in the levels of volatile trace gases within three hospital environments: implications for clinical breath testing. J Breath Res 2010;4:031001.
35. Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut 2011;60:334-340.
36. Ryu SR, Jo Y, Jung MY, et al. Hydrogen breath test in the diabetes patients with gastrointestinal symptoms. J Gastroenterol Hepatol 2010;25:A157-A1157.
37. Pohl D, Savarino E, Hersberger M, et al. Excellent agreement between genetic and hydrogen breath tests for lactase deficiency and the role of extended symptom assessment. Br J Nutr 2010;104:900-907.
38. Law D, Pimentel M. Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. Dig Dis Sci 2010;55:2302-2308.
39. Kalubowila U, Barrett JS, Shepherd SJ, et al. Fructose absorption is reduced in IBD and increased in coeliac disease using semi-quantitative analysis at breath hydrogen testing. J Gastroenterol Hepatol 2010;25:A23-A123.
40. Casellas F, Torrejon A, Vilaseca J, et al. Influence of colectomy on hydrogen excretion in breath. Int J of Colorectal Dis 2010;25:485-489.
41. Bate JP, Irving PM, Barrett JS, et al. Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol 2010;22:318-326.
42. Barrett JS, Kalubowila U, Shepherd SJ, et al. Fructose absorption is reduced in IBD and increased in coeliac disease using semi-quantitative analysis at breath hydrogen testing. J Gastroenterol Hepatol 2010;25:A96-A97.
43. Avallone EV, De Carolis A, Loizos P, et al. Hydrogen breath test - diet and basal H-2 excretion: a technical note. Digestion 2010;82:39-41.
44. Yu D, Cheeseman F, Vanner SJ. Detection of small intestinal bacterial overgrowth in irritable bowel syndrome: comparison of lactulose hydrogen breath test with scintigraphic oro-cecal transit study. Gastroenterology 2009;136:A154-A1154.
45. Chumpitazi BP, Mysore K, Shulman RJ. Impact of hydrogen breath testing on diagnosis, management, and clinical outcome in children with chronic functional GI symptoms. Gastroenterology 2009;136:A513-A1513.
46. Verbeke K, Ferchaud-Roucher V, Preston T, et al. Influence of the type of indigestible carbohydrate on plasma and urine short-chain fatty acid profiles in healthy human volunteers. Eur J Clin Nutr 2010;64:678-684.
47. Clegg ME, McKenna P, McClean C, et al. Gastrointestinal transit, postprandial lipaemia and satiety following 3 days high-fat diet in men. Eur J Clin Nutr 2011;65:240-246.
48. Ogungbenro K, Vasist L, Maclaren R, et al. A semi-mechanistic gastric emptying model for the population pharmacokinetic analysis of orally administered acetaminophen in critically ill patients. Pharm Res 2011;28:394-404.
49. Hansen KC, Schoeller DA. Effect of prior acute exercise on trafficking of dietary fat away from adipose tissue. Int J Sport Nutr Exerc Metab 2010;20:466-474.
50. Bluck LJC, Jackson SJ, Vlasakakis G, et al. Bayesian hierarchical methods to interpret the C-13-octanoic acid breath test for gastric emptying. Digestion 2011;83:96-107.
51. Carroll W, Lenney W, Wang TS, et al. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatr Pulmonol 2005;39:452-456. (Pubitemid 40548288)
52. Enderby B, Smith D, Carroll W, et al. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol 2009;44:142-147.
53. Gilchrist FJ, Alcock A, Belcher J, et al. Variation in cyanide production between different strains of Pseudomonas aeruginosa. Eur Respir J 2011;37. doi: 10.1183/09031936.00166510
54. Robroeks C, van Berkel J, Dallinga JW, et al. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res 2010;68:75-80.
55. Phillips M, Cataneo RN, Chaturvedi A, et al. Effect of influenza vaccination on oxidative stress products in breath. J Breath Res 2010;4:026001.
56. Phillips M, Cataneo RN, Saunders C, et al. Volatile biomarkers in the breath of women with breast cancer. J Breath Res 2010;4:026003. An important contribution to the use of VOCs as cancer biomarkers by one of the pioneers of breath analysis and his colleagues.
57. Amann A, Corradi M, Mazzone P, et al. Lung cancer biomarkers in exhaled breath. Exp Rev Mol Diagn 2011;11:207-217. An overview of the state-of-the art in detecting and assessing the viability of VOC biomarkers for lung cancer.
58. Poli D, Goldoni M, Corradi M, et al. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. J Chromatogr B 2010;878:2643-2651.
59. Beauchamp J, Kirsch F, Buettner A. Real-time breath gas analysis for pharmacokinetics: monitoring exhaled breath by on-line proton-transferreaction mass spectrometry after ingestion of eucalyptol-containing capsules. J Breath Res 2010;4:026006.
60. Montuschi P, Santonico M, Mondino C, et al. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Chest 2010;137:790-796. A pilot study involving seven asthma patients and seven healthy volunteers of the utility of chemical sensor arrays for breath VOC detection in diagnosing asthma carried out by leading researchers in the field.
61. Smith D, Španěl P, Sule-Suso J. Advantages of breath testing for the early diagnosis of lung cancer. Exp Rev Mol Diagn 2010;10:255-257.
62. Hryniuk A, Ross BM. A preliminary investigation of exhaled breath from patients with celiac disease using selected ion flow tube mass spectrometry. J Gastrointest Liver Dis 2010;19:15-20.
63. Martinez-Lozano P, Zingaro L, Finiguerra A, et al. Secondary electrospray ionization-mass spectrometry: breath study on a control group. J Breath Res 2011;5:016002. Secondary (or extractive) electrospray as a very sensitive method for VOC analyses shows great a promise.
64. DeGennaro G, Dragonieri S, Longobardi F, et al. Chemical characterization of exhaled breath to differentiate between patients with malignant pleural mesothelioma from subjects with similar professional asbestos exposure. Anal Bioanal Chem 2010;398:3043-3050.
65. Ulanowska A, Ligor T, Michel M, et al. Hyphenated and unconventional methods for searching volatile cancer biomarkers. Ecol Chem Eng 2010;S-17:9-23.
66. Vautz W, Nolte J, Bufe A, et al. Analyses of mouse breath with ion mobility spectrometry: a feasibility study. J Appl Physiol 2010;108:697-704.
67. Armenta S, Blanco M. Ion mobility spectrometry: a valuable tool for kinetic studies in enzymology. Anal Chim Acta 2011;685:1-8.
68. Syslová K, Kačer P, Kuzma M, et al. LC-ESI-MS/MS method for oxidative stress multimarker screening in the exhaled breath condensate of asbestosis/silicosis patients. J Breath Res 2010;4:017104.
69. Marek EM, Volke J, Hawener I, et al. Measurements of lactate in exhaled breath condensate at rest and after maximal exercise in young and healthy subjects. J Breath Res 2010;4:017105.